Red blood cell lifespan in long-term hemodialysis patients treated with roxadustat or recombinant human erythropoietin
Introduction A significant decrease in red blood cell (RBC) survival has been observed in patients with renal failure, which is supposed to contribute to renal anemia. The aim of this observational study was to determine RBC survival in hemodialysis (HD) patients treated with roxadustat or recombina...
Guardado en:
Autores principales: | Xiaowei Yang, Bing Zhao, Jing Wang, Lei Wang, Min Tao, Jing Lu, Jiangong Lin, Jing Sun, Rong Wang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Taylor & Francis Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/860b9687fd1a4d669fcb4f97bae53a00 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Relationship between hemodialysis and health-related quality of life: a cross-sectional study of diagnosis and duration of hemodialysis
por: Shinichi Noto, et al.
Publicado: (2021) -
Nomogram for predicting 1-, 5-, and 10-year survival in hemodialysis (HD) patients: a single center retrospective study
por: Han Ouyang, et al.
Publicado: (2021) -
Hemolysis in a Patient during Hemodialysis
por: Maxime Taghavi, et al.
Publicado: (2021) -
Bacteraemia by Achromobacter denitrificans in Hemodialysis
por: Venice Chavez-Valencia, et al.
Publicado: (2021) -
The association of serum magnesium with serum triglyceride and cholesterol levels in hemodialysis patients
por: Milad Fooladgar, et al.
Publicado: (2020)